Bio-Rad Laboratories, Inc. (BIO.B) vs Zimmer Biomet Holdings, Inc. (ZBH)
Bio-Rad Laboratories, Inc. and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. Zimmer Biomet Holdings, Inc. is the larger, with a market value of $17.1B against $10.3B — 1.7× the size. Zimmer Biomet Holdings, Inc. trades at the lower P/E: 22.0× against 43.8×. Zimmer Biomet Holdings, Inc. grew revenue faster over the last twelve months: 8.62% against 1.37%. Zimmer Biomet Holdings, Inc. has the higher net margin (9.48% vs 8.59%) and the higher return on invested capital (3.82% vs 0.49%). Across the 22 metrics below, Zimmer Biomet Holdings, Inc. leads on 16 and Bio-Rad Laboratories, Inc. on 6.
Valuation
Profitability
| Metric | BIO.B | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 69.87% | 56.01% |
| Operating margin | 2.05% | 14.16% | (15.03%) |
| Net margin | 8.59% | 9.48% | (20.40%) |
| Free cash flow margin | 13.64% | 12.18% | (7.24%) |
| Return on equity | 3.11% | 6.41% | (15.32%) |
| Return on assets | 2.17% | 3.53% | (19.72%) |
| Return on invested capital | 0.49% | 3.82% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack